Cetuximab for the treatment of cutaneous squamous-cell carcinoma in kidney transplant recipients – A retrospective cohort study
SAGE Publications » Journal of Onco-Nephrology
by Hila Nobel, Oded Icht, Naomi Ben Dor, Aron Popovtzer, Limor Gitter, Batya Davidovici, Ruth Rahamimov, Noga Kurman
1d ago
Journal of Onco-Nephrology, Ahead of Print. Background:Kidney transplant recipients are at high risk of developing cutaneous squamous cell carcinoma (cSCC) due to prolonged immunosuppression. While most lesions can be managed with local therapy, a subset of patients develop advanced cSCC that is unresectable, recurrent or metastatic. Immune check point inhibitors (ICI) and chemotherapy may jeopardize the transplanted kidney. Cetuximab, an anti-epidermal growth factor receptor antibody, has demonstrated efficacy in advanced cSCC, but data regarding efficacy and safety in solid organ transplant ..read more
Visit website
Acute kidney injury in Hodgkin’s lymphoma, non-Hodgkin lymphoma/leukemia, and lymphoplasmacytic lymphoma: One center experience
SAGE Publications » Journal of Onco-Nephrology
by Elena Zakharova, Tatyana Makarova, Eugenia Leonova, Elena Nikitina, Ekaterina Stolyarevich
2w ago
Journal of Onco-Nephrology, Ahead of Print. Background:Acute kidney injury (AKI) is a common complication in patients with leukemia and lymphoma. In this single-center non-interventional retrospective study from 2010 to 2022, we aimed to evaluate causes, clinical features, and pathology finding in patients with Hodgkin lymphoma (HL), non-Hodgkin lymphoma/leukemia (NHL/CLL), or lymphoplasmacytic lymphoma (LPL) and AKI.Methods:We identified 101 patients with HL, NHL/CLL, and LPL. We analyzed AKI incidence and various clinical, laboratory, and pathology parameters and outcomes.Results:About 46.5 ..read more
Visit website
Retroperitoneal lymphadenopathy: An underappreciated contributor to acute kidney failure in patients with cancer
SAGE Publications » Journal of Onco-Nephrology
by Sirisha Gudlawar, Abhilash Koratala, Wadah Jason Ayoub, Paul E Hanna
3w ago
Journal of Onco-Nephrology, Ahead of Print. Introduction:Retroperitoneal lymphadenopathy represents a unique and infrequent complication within various malignancies. This case report exemplifies the intricate diagnostic challenges that arise when identifying nondilated obstructive nephropathy in the context of retroperitoneal lymphadenopathy due to diffuse large B-cell lymphoma (DLBCL), particularly when conventional imaging fails to reveal the hallmark feature of hydronephrosis.Case description:We present a 66-year-old male with relapsed chronic lymphocytic leukemia post-allogeneic stem cell ..read more
Visit website
Palbociclib-associated nephrotoxicity in a patient with breast cancer
SAGE Publications » Journal of Onco-Nephrology
by Shao-Yu Tang, Ching-Hsiu Peng, Ting-Yun Lin, Fu-Pang Chang, Szu-Chun Hung
1M ago
Journal of Onco-Nephrology, Ahead of Print. A patient with advanced breast cancer developed acute kidney injury and generalized renal tubular dysfunction manifested as Fanconi syndrome and distal renal tubular acidosis after treatment with palbociclib, a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor. A kidney biopsy showed acute tubular injury characterized by dilated tubular lumens, flattened epithelium, and loss of brush borders, with no significant interstitial fibrosis. This case illustrates the importance of close and long-term follow-up of kidney function and electrolyte levels aft ..read more
Visit website
Dasatinib induced nephrotic range proteinuria in pediatric patient with acute lymphoblastic leukemia with hyper-eosinophilia
SAGE Publications » Journal of Onco-Nephrology
by Shaikha Alqahtani, Craig Authement, Rita Swinford, David McCall
5M ago
Journal of Onco-Nephrology, Ahead of Print. Tyrosine kinase inhibitors (TKIs) have improved outcomes for Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML). There has been reports of dasatinib induced proteinuria or nephrotic syndrome. We present a case of a 14-year-old male with high-risk B- ALL who developed nephrotic syndrome due to dasatinib. Proteinuria and nephrotic syndrome should be considered as related adverse effects from dasatinib. This is the first reported case of dasatinib induced nephrotic range proteinuria in a patient with h ..read more
Visit website
Acute interstitial nephritis secondary to sarcoid-like reaction after autologous bone marrow transplantation: Case report
SAGE Publications » Journal of Onco-Nephrology
by Luciana G Lutf, Fernando L Strufaldi, Livia B Cavalcante, Renato A Caires, Alexandre M Kawassaki, Francisco Z Mattedi, Elerson C Costalonga, Iberê C Soares, Roberta Shcolnik Szor, Verônica T Costa e Silva
5M ago
Journal of Onco-Nephrology, Ahead of Print. Sarcoid-Like Reaction is a systemic inflammatory granulomatous condition that does not meet the criteria for systemic Sarcoidosis—it is triggered by a known underlying factor, such as immunosuppression. Here we report a case of acute interstitial nephritis without granuloma in the context of a Sarcoid-Like systemic disease in the three-year period after an autologous stem cell transplant. The patient presented with a suspected relapse, associated with hemolytic anemia and an increase of serum creatinine. The investigation showed non-caseating epithel ..read more
Visit website
“Post-renal acute kidney injury in patients with cancer: Clinical presentation and kidney and patient outcomes”
SAGE Publications » Journal of Onco-Nephrology
by Círia Sousa, Marina Reis, Hugo Ferreira, Inês Coelho, Teresa Chuva, Ana Paiva, José Maximino Costa
9M ago
Journal of Onco-Nephrology, Ahead of Print. Background:Post-renal acute kidney injury (PR–AKI) is frequent in patients with cancer requiring emergent intervention. With our study we aimed to describe the clinical features and prognostic factors for kidney and overall survival (OS) in cancer patients with PR–AKI.Methods:This is a single-center retrospective study that included 306 cancer patients with PR–AKI admitted from January 2011 to December 2021. Previous kidney function, AKI episode, and progression to end-stage kidney disease (ESKD) were compared. Kaplan Meier and Cox proportional regre ..read more
Visit website
Minimal change disease onset after allogeneic stem cell transplant in donor and recipient siblings: A case report
SAGE Publications » Journal of Onco-Nephrology
by Dana S Forcey, Alan Pham, Sushrut Patil, Vincent Wong, John Brealey, Gopal Basu
10M ago
Journal of Onco-Nephrology, Ahead of Print. Kidney disease is a frequent complication after haematopoietic stem cell transplant (SCT). Glomerulopathies are reported in up to 1%–6% of allogeneic SCT recipients. Commonest cause is membranous nephropathy, followed by minimal change disease (MCD). We describe a unique case report of a patient in receipt of a SCT whose sibling donor developed nephrotic syndrome secondary to MCD followed shortly thereafter by the same in the recipient. A female in her sixties received an HLA-matched sibling donor allogeneic SCT for haematological malignancy. Six mon ..read more
Visit website
Serum cystatin C level can be used to estimate GFR in patients with solid tumors: PRO
SAGE Publications » Journal of Onco-Nephrology
by Verônica Torres
10M ago
Journal of Onco-Nephrology, Ahead of Print. An accurate assessment of glomerular filtration rate (GFR) is a fundamental aspect of cancer care and research. Recent studies have demonstrated that, in patients with solid tumors, GFR estimation based on serum creatinine combined with serum cystatin C presented minimal bias compared to measured GFR, may reduce race disparity when applied to race free GFR estimating equations, and improve the prediction of carboplatin clearance ..read more
Visit website
Chimeric antigen receptor T-cell therapy in a dialysis patient with lymphoma
SAGE Publications » Journal of Onco-Nephrology
by Muhammad Mire, Jennifer Collins, Marco Bonilla, Peter A Riedell, Jay L Koyner
11M ago
Journal of Onco-Nephrology, Ahead of Print. Chimeric antigen receptor T-cell (CAR-T) therapy has become a revolutionary cancer therapy for multiple subtypes of hematologic malignancies. Despite this progress, CAR-T use in End Stage Kidney Disease (ESKD) patients is limited. We describe the successful administration of CAR-T therapy in a patient with ESKD who had developed diffuse large B-cell lymphoma (DLBCL) from an underlying chronic lymphocytic leukemia. The patient received CAR-T therapy, preceded by lymphodepleting chemotherapy with dose-reduced fludarabine and cyclophosphamide, followed ..read more
Visit website

Follow SAGE Publications » Journal of Onco-Nephrology on FeedSpot

Continue with Google
Continue with Apple
OR